SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice

Abstract Background The objective of this research was the development and evaluation of 203Pb-labelled panitumumab (203Pb-PSC-panitumumab) as an immuno-SPECT radioligand for the detection of EGFR + head and neck squamous cell carcinoma (HNSCC) in a patient-derived xenograft (PDX) mouse model. The 5...

Full description

Saved in:

Bibliographic Details
Main Authors:	Nasim Sarrami, Bryce Nelson, Samantha Leier, John Wilson, Conrad Chan, Jalna Meens, Teesha Komal, Laurie Ailles, Melinda Wuest, Michael Schultz, Afsaneh Lavasanifar, Raymond M. Reilly, Frank Wuest
Format:	Article
Language:	English
Published:	SpringerOpen 2024-11-01
Series:	EJNMMI Radiopharmacy and Chemistry
Subjects:	Panitumumab Pb-203 Single-Photon Emission Computed Tomography (SPECT) Epidermal growth factor receptor (EGFR) Radiotheranostics Pb-212
Online Access:	https://doi.org/10.1186/s41181-024-00313-8
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

SPECT/CT imaging of EGFR-positive head and neck squamous cell carcinoma patient-derived xenografts with 203Pb-PSC-panitumumab in NRG mice

Similar Items